undefined
The trademark ASURISIL was filed by Egis Gyógyszergyár Zrt., a corporation established under the laws of Hungary (the "Applicant"). The application was published for oppositions on July 31, 2023, and received one opposition filed on September 28, 2023 by Novartis AG on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 28, 2023
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).